Literature DB >> 17131155

A clinical chameleon: postoperative hypoparathyroidism.

Thomas Bohrer1, Mark Hagemeister, Olaf Elert.   

Abstract

BACKGROUND: About 1,200 patients per year develop postoperative hypoparathyroidism alone in Germany. Many of those patients may be misdiagnosed as the symptoms of this disease may vary and can be atypical. PATIENT/
RESULTS: As an example, we describe the first known case of an elderly patient with a long history of seizures as a complication of an undiagnosed chronic hypoparathyroidism after surgery of a pT4-esophageal carcinoma. The 63-year-old male patient underwent laryngo-hypopharyngo-esophagectomy with gastric transposition and partial thyroid resection for a proximal esophageal carcinoma in 1994. About half a year later, the patient developed for the first time a convulsive syncope. Misleading diagnoses were for years suspected metastasis formation and a dumping syndrome. The general physician of the patient called him the epilepsy man, while no cause of the seizures were found. More than a decade of years later, when the correct diagnosis was made, finally by determination of parathyroid hormone levels, the seizures of the patient were completely eliminated by calcium supplementation therapy. The patient's quality of life improved clearly in the following time.
CONCLUSION: It is essential to consider chronic hypoparathyroidism in the differential diagnosis of patients with hypocalcemia who have undergone extended neck and proximal esophageal surgery before. In addition to that, it is mandatory to autotransplant parathyroids during the initial procedure which might be accidentally removed during surgery and to monitor parathyroid function in each patient in the further course postoperatively.

Entities:  

Mesh:

Year:  2006        PMID: 17131155     DOI: 10.1007/s00423-006-0113-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  5 in total

1.  Parathyroid allotransplantation without immunosuppression.

Authors:  C Hasse; G Klöck; A Schlosser; U Zimmermann; M Rothmund
Journal:  Lancet       Date:  1997-11-01       Impact factor: 79.321

2.  Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D.

Authors:  Wiebke Arlt; Christian Fremerey; Frank Callies; Martin Reincke; Peter Schneider; Wolfgang Timmermann; Bruno Allolio
Journal:  Eur J Endocrinol       Date:  2002-02       Impact factor: 6.664

3.  Hypocalcemic generalised seizures as a manifestation of iatrogenic hypoparathyroidism months to years after thyroid surgery.

Authors:  Matthias Mrowka; Susanne Knake; Harald Klinge; Per Odin; Felix Rosenow
Journal:  Epileptic Disord       Date:  2004-06       Impact factor: 1.819

4.  Hypocalcemia after thyroidectomy.

Authors:  N Demeester-Mirkine; L Hooghe; J Van Geertruyden; V De Maertelaer
Journal:  Arch Surg       Date:  1992-07

5.  Calcification of basal ganglia, postoperative hypoparathyroidism and extrapyramidal, cerebellar, pyramidal motor manifestations.

Authors:  P Kartin; M Zupevc; T Pogacnik; M Cerk
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

  5 in total
  3 in total

1.  [Postoperative hypoparathyroidism: risk factors and out-patient management following thyroid resections].

Authors:  T Franzke; C Frömke; J Jähne
Journal:  Chirurg       Date:  2010-10       Impact factor: 0.955

2.  Paratracheal lymph node dissection does not negatively affect thyroid dysfunction in patients undergoing laryngectomy.

Authors:  Annalisa M Lo Galbo; Remco de Bree; Dirk J Kuik; Paul Lips; C René Leemans
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-14       Impact factor: 2.503

3.  Total versus near-total thyroidectomy in Graves' disease and their outcome on postoperative transient hypoparathyroidism: study protocol for a randomized controlled trial?

Authors:  Katja Maschuw; Katja Schlosser; Dirk Lubbe; Christoph Nies; Detlef Klaus Bartsch
Journal:  Trials       Date:  2012-12-06       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.